UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 24, 2014
PHARMACYCLICS, INC.
|
||
(Exact name of registrant as specified in its charter)
|
||
Delaware
|
000-26658
|
94-3148201
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
995 E. Arques Avenue, Sunnyvale, California
|
94085-4521
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (408) 774-0330
xxx
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
The Compensation Committee of the Board of Directors of Pharmacyclics, Inc. (the “Company”) approved base salary increases, effective as of November 24, 2014, for the following officers: Mahkam Zanganeh, D.D.S., MBA, the Company's Chief Operating Officer, from $489,600 to $705,000, Manmeet Soni, the Company’s Chief Financial Officer, from $408,000 to $580,000 and Heow Tan, the Company’s Chief of Quality and Technical Operations, from $387,600 to $410,000.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
November 26, 2014
PHARMACYCLICS, INC.
|
|||
By:
|
/s/ Manmeet Soni | ||
Name:
|
Manmeet Soni
|
||
Title:
|
Chief Financial Officer
|